电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant PCSK9 (Evolocumab Biosimilar) 抗体

The 小鼠 单克隆 anti-PCSK9 (Evolocumab Biosimilar) antibody is suitable to detect PCSK9 (Evolocumab Biosimilar) in samples from 人. It has been validated for FACS 和 in vivo.
产品编号 ABIN7795143
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant PCSK9 (Evolocumab Biosimilar) 抗体 (ABIN7795143)

抗原

PCSK9 (Evolocumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 2
  • 1
小鼠

克隆类型

  • 3
单克隆

标记

  • 3
This PCSK9 (Evolocumab Biosimilar) antibody is un-conjugated

应用范围

  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Evolocumab Biosimilar, Human PCSK9 Monoclonal Antibody

    产品特性

    What is evolocumab biosimilar research grade? Evolocumab (trade name Repatha) is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60 % . The PCSK9 protein targets LDL receptors for degradation. Evolocumab binds to the circulating PCSK9 protein, inhibiting it from binding to the LDLR, in turn preventing PCSK9-mediated LDLR degradation and permitting the LDLR to recycle back to the liver cell surface. By inhibiting the binding of PCSK9 to LDLR, evolocumab increases the number of LDLRs available to clear LDL from the blood, thereby lowering LDL-C levels. Evolocumab biosimilar uses the same protein sequences as the therapeutic antibody evolocumab.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method

    免疫原

    Human PCSK9
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    PCSK9 (Evolocumab Biosimilar)

    别名

    Evolocumab Biosimilar

    物质类

    Biosimilar
You are here: